Procter & Gamble reports FY2025 results with modest sales growth and strong EPS momentum

Overview

P&G delivered steady sales and profit growth in fiscal 2025 despite currency headwinds and cost pressures from tariffs. The company balanced pricing actions with productivity gains to maintain healthy profitability. Strong cash flow generation supported an extended dividend streak and aggressive share repurchases. Management reaffirmed its integrated strategy and outlined cautious, but constructive, expectations for the year ahead.

“We grew sales and profit in fiscal 2025 and returned high levels of cash to shareowners in a dynamic, difficult and volatile environment. We’ve put in place strong plans to continue to deliver for all stakeholders in the current environment. In fiscal 2026, we expect to deliver another year of organic sales growth, Core EPS growth and strong adjusted free cash flow productivity. We remain committed to our integrated strategy – a focused product portfolio of daily use categories where performance drives brand choice, superiority – across product performance, packaging, brand communication, retail execution and consumer and customer value – productivity, constructive disruption and an agile and accountable organization, all aimed at delivering sustainable, balanced growth and value creation”, said Jon Moeller, Chairman of the Board, President and Chief Executive Officer.

Fiscal Year 2025 vs. 2024:

Net sales reached $84.3bn (flat YoY) as a 1% pricing benefit was offset by a 1% drag from foreign exchange.
Organic sales grew 2%, driven equally by pricing and volume gains.
Diluted GAAP EPS rose to $6.51 (+8% YoY), helped by lower SG&A and a prior-year non-cash impairment charge on Gillette assets.
Core EPS increased to $6.83 (+4% YoY), or 5% on a currency-neutral basis.
Operating cash flow totaled $17.8bn, with adjusted free cash flow productivity at 87%.
The company returned over $16bn to shareholders, including $9.9bn in dividends and $6.5bn in share buybacks, marking its 69th consecutive dividend increase.

Q4 FY2025 vs. Q4 FY2024:

Net sales grew to $20.9bn (+2% YoY), with organic sales up 2% driven by mix and pricing.
- Beauty: Organic +1%, supported by volume gains in Latin America and Europe despite declines in North America & Greater China; hair care flat, skin & personal care stable.
- Grooming: Organic +1%, driven by innovation-powered pricing; partially offset by lower appliances volume.
- Health Care: Organic +2%, with oral and personal care brands leading due to pricing and mix; volume decline tied to lower incidence of cough/cold.
- Fabric & Home Care: Organic +1%, driven by fabric care innovation in North America and volume growth in home care across key regions.
- Baby, Feminine & Family Care: Organic +1%; baby care dipped slightly while feminine care and family care saw low-single-digit growth from mix and volume improvements.
Diluted EPS increased to $1.48 (+17% YoY), boosted by favorable comparison to prior-year restructuring charges in Enterprise Markets.
Core EPS rose to $1.48 (+6% YoY), or 5% on a currency-neutral basis.
Operating cash flow was $5.0bn, and adjusted free cash flow productivity reached 110%.

P&G provided full-year FY 2026 guidance with balanced optimism tempered by macro uncertainty. Full-year net sales projected to grow 1%-5%, with organic sales expected between flat and +4%, including a modest 30-50 bps headwind from form and brand exits. GAAP EPS growth is expected in the 3%-9% range, while core EPS is projected flat to up 4%, implying a range of $6.83-$7.09 per share. Headwinds include approximately $1bn in pre-tax tariff costs, along with $200m in commodity cost pressures and $250m from rising interest expenses; FX tailwind estimated at $300m. The company plans to streamline operations via its June productivity plan, including up to 7,000 non-manufacturing job cuts through FY 2027 to fund future investments and offset cost inflation. A smooth leadership transition is planned, with current COO Shailesh Jejurikar named CEO effective January 1, 2026; Jon Moeller will become executive chairman. P&G remains committed to its integrated growth model centered on productivity, brand investment, innovation, and value creation despite ongoing volatility.

P&G is trading down 0.95%, and remains below both the 50-day SMA and 200-day SMA, signaling a bearish short- to medium-term trend. The RSI (14) is at 41.87, near the lower end of the neutral range, indicating weak momentum but not yet oversold. Immediate support is around $152-$153, with resistance near $161, the 50-day SMA. A breakout above $161 would signal a potential short-term reversal, while a drop below $152 could extend the downtrend.